Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
0.00%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 496 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Market Cap
$4.79M
Operating Margin
-1128.11%
TTM Avg
-14522.19%
3Y Avg
-8776.16%
5Y Avg
-5850.77%
Market Cap
$4.96M
Operating Margin
-19.28%
TTM Avg
1.28%
3Y Avg
11.60%
5Y Avg
11.60%
Market Cap
$4.99M
Operating Margin
-3317.65%
TTM Avg
-1658.83%
3Y Avg
-2341.84%
5Y Avg
-1561.23%
Market Cap
$5.21M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-1246.08%
5Y Avg
-2147.17%
Market Cap
$4.46M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$4.42M
Operating Margin
-484.31%
TTM Avg
-1917.01%
3Y Avg
-2405.16%
5Y Avg
-1618.57%
Market Cap
$4.41M
Operating Margin
0.00%
TTM Avg
-1346.57%
3Y Avg
-8443.50%
5Y Avg
-5629.00%
Market Cap
$5.36M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CalciMedica, Inc. (CALC) | $4.85M | 0.00% | 0.00% | 0.00% | 0.00% |
| Bio Green Med Solution, Inc. (BGMS)vs › | $4.79M | -1128.11% | -14522.19% | -8776.16% | -5850.77% |
| Basel Medical Group Ltd Ordinary Shares (BMGL)vs › | $4.96M | -19.28% | 1.28% | 11.60% | 11.60% |
| Gelteq Limited Ordinary Shares (GELS)vs › | $4.99M | -3317.65% | -1658.83% | -2341.84% | -1561.23% |
| Imunon, Inc. (IMNN)vs › | $5.21M | 0.00% | 0.00% | -1246.08% | -2147.17% |
| Dermata Therapeutics, Inc. (DRMA)vs › | $4.46M | 0.00% | 0.00% | 0.00% | 0.00% |
| CollPlant Biotechnologies Ltd. (CLGN)vs › | $4.42M | -484.31% | -1917.01% | -2405.16% | -1618.57% |
| Ernexa Therapeutics Inc. (ERNA)vs › | $4.41M | 0.00% | -1346.57% | -8443.50% | -5629.00% |
| Alzamend Neuro Inc (ALZN)vs › | $5.36M | 0.00% | 0.00% | 0.00% | 0.00% |
| 20/20 Biolabs Inc. (AIDX)vs › | $4.32M | -162.87% | -242.97% | -229.35% | -164.06% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
